Table 5.
No systemic illness | Underlying systemic illness | P | 95% C.I. | |
---|---|---|---|---|
Number of eyes | 117 | 56 | ||
Male gender (%) | 64 (54.7%) | 32 (57.1%) | 0.76 | |
Mean age (years) | 23.15±19.84 Median 20 | 30.14±24.09 Median 29 | 0.02 | 1-14 |
Blood culture positivity (%) | 0 | 1 (1.78%) | 0.14 | |
Urine culture positivity (%) | 3 (2.56%) | 8 (14.28%) | 0.003 | 3.4%-23.29% |
Vitreous culture positivity (%) | 114 (97.43%) | 47 (83.92%) | 0.001 | 4.75%-25.36% |
Gram-negative etiology (%) | 33 (28.2%) | 31 (55.35%) | 0.0006 | 11.52%-41.44% |
Fungal etiology (%) | 11 (9.4%) | 13 (23.21%) | 0.01 | 2.52%-27% |
Vitrectomy done (%) | 78 (67.2%) | 36 (64.3%) | 0.7 | |
Favorable functional outcome (%) | 27 (23.07%) | 18 (32.14) | 0.2 | |
Favorable anatomic outcome (%) | 54 (46.15%) | 22 (39.28%) | 0.39 | |
Rate of evisceration or enucleation (%) | 2 (1.7%) | 7 (12.5%) | 0.002 | 3.16%-21.99% |